Shanghai Fudan Zhangjiang Bio Pharmaceutical Co (DE:FDY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co has invested RMB180 million in a low-risk structured deposit product with Bank of China, using proceeds from its A-share public offering. The investment is tied to the USD/JPY spot rate and guarantees the principal with an expected annualized return rate between 1.1000% and 2.1444%. This financial move is significant enough to require disclosure but not shareholder approval.
For further insights into DE:FDY stock, check out TipRanks’ Stock Analysis page.
